nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—atherosclerosis	0.19	1	CbGaD
Enzalutamide—ALB—Rosuvastatin—atherosclerosis	0.0373	0.0612	CbGbCtD
Enzalutamide—CYP2B6—Simvastatin—atherosclerosis	0.0354	0.0581	CbGbCtD
Enzalutamide—CYP3A5—Rosuvastatin—atherosclerosis	0.03	0.0492	CbGbCtD
Enzalutamide—CYP3A5—Simvastatin—atherosclerosis	0.0278	0.0457	CbGbCtD
Enzalutamide—CYP3A5—Pravastatin—atherosclerosis	0.0273	0.0448	CbGbCtD
Enzalutamide—CYP3A5—Lovastatin—atherosclerosis	0.0273	0.0448	CbGbCtD
Enzalutamide—CYP2C8—Simvastatin—atherosclerosis	0.0268	0.044	CbGbCtD
Enzalutamide—CYP2C8—Pravastatin—atherosclerosis	0.0262	0.043	CbGbCtD
Enzalutamide—CYP2C8—Lovastatin—atherosclerosis	0.0262	0.043	CbGbCtD
Enzalutamide—CYP2C19—Rosuvastatin—atherosclerosis	0.0242	0.0397	CbGbCtD
Enzalutamide—CYP2C19—Simvastatin—atherosclerosis	0.0225	0.0369	CbGbCtD
Enzalutamide—CYP2C19—Lovastatin—atherosclerosis	0.022	0.0361	CbGbCtD
Enzalutamide—CYP2D6—Niacin—atherosclerosis	0.0216	0.0355	CbGbCtD
Enzalutamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0201	0.033	CbGbCtD
Enzalutamide—ABCB1—Ezetimibe—atherosclerosis	0.0195	0.032	CbGbCtD
Enzalutamide—CYP2C9—Simvastatin—atherosclerosis	0.0187	0.0307	CbGbCtD
Enzalutamide—CYP2C9—Lovastatin—atherosclerosis	0.0183	0.03	CbGbCtD
Enzalutamide—CYP2C9—Pravastatin—atherosclerosis	0.0183	0.03	CbGbCtD
Enzalutamide—ABCB1—Simvastatin—atherosclerosis	0.0181	0.0298	CbGbCtD
Enzalutamide—ABCB1—Lovastatin—atherosclerosis	0.0177	0.0291	CbGbCtD
Enzalutamide—ABCB1—Pravastatin—atherosclerosis	0.0177	0.0291	CbGbCtD
Enzalutamide—CYP2D6—Simvastatin—atherosclerosis	0.0171	0.0281	CbGbCtD
Enzalutamide—CYP2D6—Pravastatin—atherosclerosis	0.0167	0.0275	CbGbCtD
Enzalutamide—CYP2D6—Lovastatin—atherosclerosis	0.0167	0.0275	CbGbCtD
Enzalutamide—CYP3A4—Ezetimibe—atherosclerosis	0.0117	0.0192	CbGbCtD
Enzalutamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0117	0.0192	CbGbCtD
Enzalutamide—CYP3A4—Simvastatin—atherosclerosis	0.0109	0.0178	CbGbCtD
Enzalutamide—CYP3A4—Pravastatin—atherosclerosis	0.0106	0.0175	CbGbCtD
Enzalutamide—CYP3A4—Lovastatin—atherosclerosis	0.0106	0.0175	CbGbCtD
Enzalutamide—Lung infection—Pravastatin—atherosclerosis	0.00763	0.0619	CcSEcCtD
Enzalutamide—Cognitive disorder—Rosuvastatin—atherosclerosis	0.00404	0.0328	CcSEcCtD
Enzalutamide—Cognitive disorder—Lovastatin—atherosclerosis	0.00343	0.0278	CcSEcCtD
Enzalutamide—Cognitive disorder—Ezetimibe—atherosclerosis	0.00336	0.0272	CcSEcCtD
Enzalutamide—Cognitive disorder—Simvastatin—atherosclerosis	0.0032	0.026	CcSEcCtD
Enzalutamide—Cognitive disorder—Pravastatin—atherosclerosis	0.0029	0.0235	CcSEcCtD
Enzalutamide—Memory impairment—Rosuvastatin—atherosclerosis	0.00223	0.0181	CcSEcCtD
Enzalutamide—Memory impairment—Lovastatin—atherosclerosis	0.00189	0.0153	CcSEcCtD
Enzalutamide—Memory impairment—Ezetimibe—atherosclerosis	0.00185	0.015	CcSEcCtD
Enzalutamide—Memory impairment—Simvastatin—atherosclerosis	0.00177	0.0143	CcSEcCtD
Enzalutamide—Laryngitis—Niacin—atherosclerosis	0.00177	0.0143	CcSEcCtD
Enzalutamide—Memory impairment—Pravastatin—atherosclerosis	0.0016	0.0129	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Lovastatin—atherosclerosis	0.0015	0.0122	CcSEcCtD
Enzalutamide—Injury—Rosuvastatin—atherosclerosis	0.00138	0.0112	CcSEcCtD
Enzalutamide—Amnesia—Rosuvastatin—atherosclerosis	0.00135	0.0109	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00127	0.0103	CcSEcCtD
Enzalutamide—Injury—Lovastatin—atherosclerosis	0.00117	0.00948	CcSEcCtD
Enzalutamide—Amnesia—Lovastatin—atherosclerosis	0.00114	0.00928	CcSEcCtD
Enzalutamide—Hot flush—Ezetimibe—atherosclerosis	0.00113	0.00914	CcSEcCtD
Enzalutamide—Amnesia—Ezetimibe—atherosclerosis	0.00112	0.0091	CcSEcCtD
Enzalutamide—Muscular weakness—Rosuvastatin—atherosclerosis	0.00112	0.00907	CcSEcCtD
Enzalutamide—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00112	0.00906	CcSEcCtD
Enzalutamide—Amnesia—Simvastatin—atherosclerosis	0.00107	0.00868	CcSEcCtD
Enzalutamide—Bronchitis—Rosuvastatin—atherosclerosis	0.00105	0.00855	CcSEcCtD
Enzalutamide—Injury—Pravastatin—atherosclerosis	0.000989	0.00802	CcSEcCtD
Enzalutamide—Hot flush—Pravastatin—atherosclerosis	0.000972	0.00788	CcSEcCtD
Enzalutamide—Amnesia—Pravastatin—atherosclerosis	0.000968	0.00785	CcSEcCtD
Enzalutamide—Menopausal symptoms—Pravastatin—atherosclerosis	0.000964	0.00781	CcSEcCtD
Enzalutamide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000943	0.00765	CcSEcCtD
Enzalutamide—Haematuria—Rosuvastatin—atherosclerosis	0.000932	0.00756	CcSEcCtD
Enzalutamide—Muscular weakness—Ezetimibe—atherosclerosis	0.00093	0.00754	CcSEcCtD
Enzalutamide—Sinusitis—Rosuvastatin—atherosclerosis	0.000917	0.00744	CcSEcCtD
Enzalutamide—Muscular weakness—Simvastatin—atherosclerosis	0.000887	0.00719	CcSEcCtD
Enzalutamide—Rhinitis—Rosuvastatin—atherosclerosis	0.00088	0.00713	CcSEcCtD
Enzalutamide—Pharyngitis—Rosuvastatin—atherosclerosis	0.000871	0.00706	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000847	0.00687	CcSEcCtD
Enzalutamide—Dry skin—Niacin—atherosclerosis	0.000847	0.00686	CcSEcCtD
Enzalutamide—Bronchitis—Simvastatin—atherosclerosis	0.000836	0.00678	CcSEcCtD
Enzalutamide—Dry skin—Pravastatin—atherosclerosis	0.000834	0.00676	CcSEcCtD
Enzalutamide—Muscular weakness—Niacin—atherosclerosis	0.000815	0.0066	CcSEcCtD
Enzalutamide—Nasopharyngitis—Pravastatin—atherosclerosis	0.000813	0.00659	CcSEcCtD
Enzalutamide—Infestation NOS—Ezetimibe—atherosclerosis	0.000813	0.00659	CcSEcCtD
Enzalutamide—Infestation—Ezetimibe—atherosclerosis	0.000813	0.00659	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000808	0.00655	CcSEcCtD
Enzalutamide—Muscular weakness—Pravastatin—atherosclerosis	0.000802	0.0065	CcSEcCtD
Enzalutamide—Sinusitis—Lovastatin—atherosclerosis	0.000778	0.0063	CcSEcCtD
Enzalutamide—Mental disorder—Rosuvastatin—atherosclerosis	0.000769	0.00623	CcSEcCtD
Enzalutamide—Bronchitis—Niacin—atherosclerosis	0.000768	0.00622	CcSEcCtD
Enzalutamide—Sinusitis—Ezetimibe—atherosclerosis	0.000763	0.00618	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000731	0.00592	CcSEcCtD
Enzalutamide—Sinusitis—Simvastatin—atherosclerosis	0.000727	0.0059	CcSEcCtD
Enzalutamide—Pharyngitis—Ezetimibe—atherosclerosis	0.000724	0.00587	CcSEcCtD
Enzalutamide—Oedema peripheral—Ezetimibe—atherosclerosis	0.000719	0.00583	CcSEcCtD
Enzalutamide—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000717	0.00581	CcSEcCtD
Enzalutamide—Angiopathy—Ezetimibe—atherosclerosis	0.000662	0.00537	CcSEcCtD
Enzalutamide—Sinusitis—Pravastatin—atherosclerosis	0.000658	0.00533	CcSEcCtD
Enzalutamide—Arthralgia—Rosuvastatin—atherosclerosis	0.000651	0.00527	CcSEcCtD
Enzalutamide—Rhinitis—Niacin—atherosclerosis	0.000641	0.00519	CcSEcCtD
Enzalutamide—Mental disorder—Ezetimibe—atherosclerosis	0.000639	0.00518	CcSEcCtD
Enzalutamide—Hypoaesthesia—Niacin—atherosclerosis	0.000636	0.00515	CcSEcCtD
Enzalutamide—Rhinitis—Pravastatin—atherosclerosis	0.000631	0.00511	CcSEcCtD
Enzalutamide—Oedema peripheral—Niacin—atherosclerosis	0.000629	0.0051	CcSEcCtD
Enzalutamide—Back pain—Lovastatin—atherosclerosis	0.000626	0.00508	CcSEcCtD
Enzalutamide—Hypoaesthesia—Pravastatin—atherosclerosis	0.000626	0.00507	CcSEcCtD
Enzalutamide—Pharyngitis—Pravastatin—atherosclerosis	0.000624	0.00506	CcSEcCtD
Enzalutamide—Infection—Rosuvastatin—atherosclerosis	0.00062	0.00502	CcSEcCtD
Enzalutamide—Back pain—Ezetimibe—atherosclerosis	0.000614	0.00498	CcSEcCtD
Enzalutamide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000612	0.00496	CcSEcCtD
Enzalutamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000611	0.00495	CcSEcCtD
Enzalutamide—Mental disorder—Simvastatin—atherosclerosis	0.00061	0.00494	CcSEcCtD
Enzalutamide—Vertigo—Lovastatin—atherosclerosis	0.000582	0.00472	CcSEcCtD
Enzalutamide—Angiopathy—Niacin—atherosclerosis	0.00058	0.0047	CcSEcCtD
Enzalutamide—Leukopenia—Lovastatin—atherosclerosis	0.00058	0.0047	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000568	0.00461	CcSEcCtD
Enzalutamide—Insomnia—Rosuvastatin—atherosclerosis	0.000564	0.00457	CcSEcCtD
Enzalutamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00056	0.00454	CcSEcCtD
Enzalutamide—Arthralgia—Lovastatin—atherosclerosis	0.000551	0.00447	CcSEcCtD
Enzalutamide—Anxiety—Lovastatin—atherosclerosis	0.000549	0.00445	CcSEcCtD
Enzalutamide—Hypertension—Ezetimibe—atherosclerosis	0.000548	0.00445	CcSEcCtD
Enzalutamide—Vertigo—Simvastatin—atherosclerosis	0.000544	0.00441	CcSEcCtD
Enzalutamide—Leukopenia—Simvastatin—atherosclerosis	0.000542	0.0044	CcSEcCtD
Enzalutamide—Arthralgia—Ezetimibe—atherosclerosis	0.000541	0.00438	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000537	0.00435	CcSEcCtD
Enzalutamide—Infection—Lovastatin—atherosclerosis	0.000525	0.00426	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000518	0.0042	CcSEcCtD
Enzalutamide—Arthralgia—Simvastatin—atherosclerosis	0.000516	0.00418	CcSEcCtD
Enzalutamide—Infection—Ezetimibe—atherosclerosis	0.000515	0.00417	CcSEcCtD
Enzalutamide—Anxiety—Simvastatin—atherosclerosis	0.000514	0.00417	CcSEcCtD
Enzalutamide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000508	0.00412	CcSEcCtD
Enzalutamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000508	0.00411	CcSEcCtD
Enzalutamide—Skin disorder—Ezetimibe—atherosclerosis	0.000504	0.00408	CcSEcCtD
Enzalutamide—Vertigo—Niacin—atherosclerosis	0.0005	0.00405	CcSEcCtD
Enzalutamide—Leukopenia—Niacin—atherosclerosis	0.000498	0.00404	CcSEcCtD
Enzalutamide—Vertigo—Pravastatin—atherosclerosis	0.000492	0.00399	CcSEcCtD
Enzalutamide—Infection—Simvastatin—atherosclerosis	0.000491	0.00398	CcSEcCtD
Enzalutamide—Leukopenia—Pravastatin—atherosclerosis	0.00049	0.00397	CcSEcCtD
Enzalutamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000484	0.00392	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000482	0.0039	CcSEcCtD
Enzalutamide—Insomnia—Lovastatin—atherosclerosis	0.000478	0.00388	CcSEcCtD
Enzalutamide—Paraesthesia—Lovastatin—atherosclerosis	0.000475	0.00385	CcSEcCtD
Enzalutamide—Arthralgia—Niacin—atherosclerosis	0.000474	0.00384	CcSEcCtD
Enzalutamide—Hypertension—Pravastatin—atherosclerosis	0.000473	0.00383	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000472	0.00383	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00047	0.00381	CcSEcCtD
Enzalutamide—Insomnia—Ezetimibe—atherosclerosis	0.000469	0.0038	CcSEcCtD
Enzalutamide—Arthralgia—Pravastatin—atherosclerosis	0.000466	0.00378	CcSEcCtD
Enzalutamide—Paraesthesia—Ezetimibe—atherosclerosis	0.000466	0.00377	CcSEcCtD
Enzalutamide—Anxiety—Pravastatin—atherosclerosis	0.000465	0.00377	CcSEcCtD
Enzalutamide—Fatigue—Lovastatin—atherosclerosis	0.000456	0.00369	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00045	0.00365	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000448	0.00363	CcSEcCtD
Enzalutamide—Asthenia—Rosuvastatin—atherosclerosis	0.000447	0.00363	CcSEcCtD
Enzalutamide—Insomnia—Simvastatin—atherosclerosis	0.000447	0.00362	CcSEcCtD
Enzalutamide—Fatigue—Ezetimibe—atherosclerosis	0.000447	0.00362	CcSEcCtD
Enzalutamide—Infection—Pravastatin—atherosclerosis	0.000444	0.0036	CcSEcCtD
Enzalutamide—Paraesthesia—Simvastatin—atherosclerosis	0.000444	0.0036	CcSEcCtD
Enzalutamide—Pruritus—Rosuvastatin—atherosclerosis	0.000441	0.00358	CcSEcCtD
Enzalutamide—Skin disorder—Niacin—atherosclerosis	0.000441	0.00357	CcSEcCtD
Enzalutamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000438	0.00355	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000427	0.00346	CcSEcCtD
Enzalutamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000427	0.00346	CcSEcCtD
Enzalutamide—Fatigue—Simvastatin—atherosclerosis	0.000426	0.00346	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000414	0.00335	CcSEcCtD
Enzalutamide—Dizziness—Rosuvastatin—atherosclerosis	0.000412	0.00334	CcSEcCtD
Enzalutamide—Insomnia—Niacin—atherosclerosis	0.000411	0.00333	CcSEcCtD
Enzalutamide—Paraesthesia—Niacin—atherosclerosis	0.000408	0.0033	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000407	0.0033	CcSEcCtD
Enzalutamide—Insomnia—Pravastatin—atherosclerosis	0.000404	0.00328	CcSEcCtD
Enzalutamide—Paraesthesia—Pravastatin—atherosclerosis	0.000401	0.00325	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000392	0.00318	CcSEcCtD
Enzalutamide—Headache—Rosuvastatin—atherosclerosis	0.000391	0.00317	CcSEcCtD
Enzalutamide—Fatigue—Pravastatin—atherosclerosis	0.000385	0.00312	CcSEcCtD
Enzalutamide—Asthenia—Lovastatin—atherosclerosis	0.000379	0.00307	CcSEcCtD
Enzalutamide—Pruritus—Lovastatin—atherosclerosis	0.000374	0.00303	CcSEcCtD
Enzalutamide—Asthenia—Ezetimibe—atherosclerosis	0.000372	0.00302	CcSEcCtD
Enzalutamide—Pruritus—Ezetimibe—atherosclerosis	0.000367	0.00297	CcSEcCtD
Enzalutamide—Diarrhoea—Lovastatin—atherosclerosis	0.000362	0.00293	CcSEcCtD
Enzalutamide—Asthenia—Simvastatin—atherosclerosis	0.000355	0.00288	CcSEcCtD
Enzalutamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000355	0.00288	CcSEcCtD
Enzalutamide—Pruritus—Simvastatin—atherosclerosis	0.00035	0.00284	CcSEcCtD
Enzalutamide—Dizziness—Lovastatin—atherosclerosis	0.00035	0.00283	CcSEcCtD
Enzalutamide—Dizziness—Ezetimibe—atherosclerosis	0.000343	0.00278	CcSEcCtD
Enzalutamide—Diarrhoea—Simvastatin—atherosclerosis	0.000338	0.00274	CcSEcCtD
Enzalutamide—Headache—Lovastatin—atherosclerosis	0.000331	0.00268	CcSEcCtD
Enzalutamide—Dizziness—Simvastatin—atherosclerosis	0.000327	0.00265	CcSEcCtD
Enzalutamide—Asthenia—Niacin—atherosclerosis	0.000326	0.00264	CcSEcCtD
Enzalutamide—Headache—Ezetimibe—atherosclerosis	0.000325	0.00263	CcSEcCtD
Enzalutamide—Pruritus—Niacin—atherosclerosis	0.000321	0.0026	CcSEcCtD
Enzalutamide—Asthenia—Pravastatin—atherosclerosis	0.000321	0.0026	CcSEcCtD
Enzalutamide—Pruritus—Pravastatin—atherosclerosis	0.000316	0.00256	CcSEcCtD
Enzalutamide—Diarrhoea—Niacin—atherosclerosis	0.000311	0.00252	CcSEcCtD
Enzalutamide—Headache—Simvastatin—atherosclerosis	0.00031	0.00251	CcSEcCtD
Enzalutamide—Diarrhoea—Pravastatin—atherosclerosis	0.000306	0.00248	CcSEcCtD
Enzalutamide—Dizziness—Niacin—atherosclerosis	0.0003	0.00243	CcSEcCtD
Enzalutamide—Dizziness—Pravastatin—atherosclerosis	0.000296	0.0024	CcSEcCtD
Enzalutamide—Headache—Niacin—atherosclerosis	0.000284	0.00231	CcSEcCtD
Enzalutamide—Headache—Pravastatin—atherosclerosis	0.00028	0.00227	CcSEcCtD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.98e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NAMPT—atherosclerosis	9.97e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.96e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.91e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LIPC—atherosclerosis	9.9e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.89e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOC3—atherosclerosis	9.84e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LDLR—atherosclerosis	9.78e-06	0.000126	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NAMPT—atherosclerosis	9.73e-06	0.000125	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMGCR—atherosclerosis	9.68e-06	0.000125	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LIPC—atherosclerosis	9.67e-06	0.000125	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMGCR—atherosclerosis	9.63e-06	0.000124	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOC3—atherosclerosis	9.61e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CETP—atherosclerosis	9.55e-06	0.000123	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LDLR—atherosclerosis	9.55e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.36e-06	0.000121	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CETP—atherosclerosis	9.33e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FABP4—atherosclerosis	9.3e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LCAT—atherosclerosis	9.3e-06	0.00012	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	9.3e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NAMPT—atherosclerosis	9.17e-06	0.000118	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.16e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SCARB1—atherosclerosis	9.15e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA4—atherosclerosis	9.13e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LIPC—atherosclerosis	9.11e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	9.09e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOC3—atherosclerosis	9.05e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.03e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LIPC—atherosclerosis	9.03e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LDLR—atherosclerosis	9e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOC3—atherosclerosis	8.97e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.97e-06	0.000116	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SCARB1—atherosclerosis	8.93e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LDLR—atherosclerosis	8.92e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.91e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CETP—atherosclerosis	8.79e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HMOX1—atherosclerosis	8.74e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.73e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CETP—atherosclerosis	8.71e-06	0.000112	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.68e-06	0.000112	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.64e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.63e-06	0.000111	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCA1—atherosclerosis	8.58e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HMOX1—atherosclerosis	8.55e-06	0.00011	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMGCR—atherosclerosis	8.43e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.42e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOB—atherosclerosis	8.38e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.34e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.29e-06	0.000107	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.27e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOB—atherosclerosis	8.19e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—atherosclerosis	8.15e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.12e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—LPL—atherosclerosis	8e-06	0.000103	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAPK3—atherosclerosis	7.97e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.96e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.95e-06	0.000102	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.88e-06	0.000102	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.86e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.86e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.86e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA2—atherosclerosis	7.86e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—LPL—atherosclerosis	7.82e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GPX1—atherosclerosis	7.8e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.79e-06	0.0001	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.76e-06	0.0001	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.7e-06	9.92e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GPX1—atherosclerosis	7.63e-06	9.83e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD36—atherosclerosis	7.6e-06	9.79e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ABCA1—atherosclerosis	7.52e-06	9.69e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—atherosclerosis	7.51e-06	9.68e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPA—atherosclerosis	7.5e-06	9.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD36—atherosclerosis	7.43e-06	9.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—atherosclerosis	7.4e-06	9.54e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—atherosclerosis	7.36e-06	9.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BGN—atherosclerosis	7.26e-06	9.35e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—atherosclerosis	7.2e-06	9.28e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA5—atherosclerosis	7.19e-06	9.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.11e-06	9.16e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—atherosclerosis	7.11e-06	9.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOB—atherosclerosis	7.09e-06	9.14e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCA1—atherosclerosis	7.08e-06	9.13e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARA—atherosclerosis	7.06e-06	9.1e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOB—atherosclerosis	7.05e-06	9.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.04e-06	9.07e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.02e-06	9.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.92e-06	8.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARA—atherosclerosis	6.9e-06	8.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.9e-06	8.89e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—atherosclerosis	6.89e-06	8.88e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—atherosclerosis	6.86e-06	8.84e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AGT—atherosclerosis	6.84e-06	8.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—LPL—atherosclerosis	6.77e-06	8.72e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—LPL—atherosclerosis	6.73e-06	8.67e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—atherosclerosis	6.7e-06	8.64e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AGT—atherosclerosis	6.69e-06	8.62e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.68e-06	8.61e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAV1—atherosclerosis	6.64e-06	8.56e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOA1—atherosclerosis	6.63e-06	8.54e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.61e-06	8.51e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—atherosclerosis	6.61e-06	8.51e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—atherosclerosis	6.57e-06	8.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—atherosclerosis	6.55e-06	8.44e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAV1—atherosclerosis	6.49e-06	8.36e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOA1—atherosclerosis	6.48e-06	8.35e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—atherosclerosis	6.45e-06	8.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD36—atherosclerosis	6.43e-06	8.29e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD36—atherosclerosis	6.4e-06	8.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOB—atherosclerosis	6.33e-06	8.15e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOB—atherosclerosis	6.18e-06	7.96e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.16e-06	7.93e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—atherosclerosis	6.1e-06	7.85e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.08e-06	7.83e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—atherosclerosis	6.06e-06	7.81e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—atherosclerosis	6.05e-06	7.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LPL—atherosclerosis	6.04e-06	7.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.02e-06	7.76e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—atherosclerosis	6.01e-06	7.74e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.99e-06	7.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARA—atherosclerosis	5.98e-06	7.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LIPC—atherosclerosis	5.96e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARA—atherosclerosis	5.95e-06	7.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOC3—atherosclerosis	5.92e-06	7.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.91e-06	7.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LPL—atherosclerosis	5.9e-06	7.6e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—atherosclerosis	5.9e-06	7.6e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LDLR—atherosclerosis	5.88e-06	7.58e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—atherosclerosis	5.84e-06	7.52e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOB—atherosclerosis	5.82e-06	7.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AGT—atherosclerosis	5.79e-06	7.46e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOB—atherosclerosis	5.77e-06	7.44e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AGT—atherosclerosis	5.76e-06	7.42e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—atherosclerosis	5.75e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CETP—atherosclerosis	5.75e-06	7.4e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD36—atherosclerosis	5.74e-06	7.4e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—INS—atherosclerosis	5.73e-06	7.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—atherosclerosis	5.71e-06	7.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—atherosclerosis	5.68e-06	7.31e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.66e-06	7.3e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—atherosclerosis	5.64e-06	7.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAV1—atherosclerosis	5.62e-06	7.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.61e-06	7.23e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOA1—atherosclerosis	5.61e-06	7.23e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD36—atherosclerosis	5.6e-06	7.22e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—INS—atherosclerosis	5.6e-06	7.21e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAV1—atherosclerosis	5.59e-06	7.2e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOA1—atherosclerosis	5.58e-06	7.19e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LPL—atherosclerosis	5.56e-06	7.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LPL—atherosclerosis	5.51e-06	7.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.5e-06	7.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.44e-06	7.01e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—atherosclerosis	5.42e-06	6.99e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—atherosclerosis	5.38e-06	6.93e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—atherosclerosis	5.37e-06	6.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARA—atherosclerosis	5.34e-06	6.88e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—atherosclerosis	5.31e-06	6.84e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD36—atherosclerosis	5.28e-06	6.8e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—atherosclerosis	5.25e-06	6.76e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD36—atherosclerosis	5.24e-06	6.75e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARA—atherosclerosis	5.21e-06	6.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.2e-06	6.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AGT—atherosclerosis	5.17e-06	6.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—atherosclerosis	5.13e-06	6.61e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.12e-06	6.6e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—atherosclerosis	5.09e-06	6.56e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—atherosclerosis	5.07e-06	6.53e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AGT—atherosclerosis	5.05e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—atherosclerosis	5.02e-06	6.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAV1—atherosclerosis	5.02e-06	6.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOA1—atherosclerosis	5.01e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—atherosclerosis	5e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.96e-06	6.39e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—atherosclerosis	4.94e-06	6.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—atherosclerosis	4.94e-06	6.37e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—atherosclerosis	4.92e-06	6.33e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARA—atherosclerosis	4.91e-06	6.33e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—atherosclerosis	4.91e-06	6.32e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAV1—atherosclerosis	4.9e-06	6.31e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOA1—atherosclerosis	4.89e-06	6.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARA—atherosclerosis	4.87e-06	6.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—INS—atherosclerosis	4.85e-06	6.25e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—INS—atherosclerosis	4.82e-06	6.21e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—atherosclerosis	4.79e-06	6.18e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AGT—atherosclerosis	4.76e-06	6.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AGT—atherosclerosis	4.71e-06	6.07e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—atherosclerosis	4.66e-06	6e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.63e-06	5.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—atherosclerosis	4.62e-06	5.95e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAV1—atherosclerosis	4.62e-06	5.95e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOA1—atherosclerosis	4.61e-06	5.93e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—atherosclerosis	4.59e-06	5.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAV1—atherosclerosis	4.58e-06	5.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.57e-06	5.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOA1—atherosclerosis	4.57e-06	5.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.49e-06	5.78e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.46e-06	5.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—atherosclerosis	4.44e-06	5.73e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—atherosclerosis	4.41e-06	5.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—INS—atherosclerosis	4.33e-06	5.58e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—atherosclerosis	4.31e-06	5.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—atherosclerosis	4.25e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—atherosclerosis	4.23e-06	5.45e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—INS—atherosclerosis	4.22e-06	5.44e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.2e-06	5.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.17e-06	5.37e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—atherosclerosis	4.06e-06	5.23e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—atherosclerosis	4.02e-06	5.18e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—INS—atherosclerosis	3.98e-06	5.13e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.97e-06	5.12e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—atherosclerosis	3.97e-06	5.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—INS—atherosclerosis	3.95e-06	5.08e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.89e-06	5.01e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—atherosclerosis	3.87e-06	4.99e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—atherosclerosis	3.87e-06	4.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOB—atherosclerosis	3.81e-06	4.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—atherosclerosis	3.8e-06	4.89e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—atherosclerosis	3.7e-06	4.77e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.7e-06	4.77e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—atherosclerosis	3.65e-06	4.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPL—atherosclerosis	3.63e-06	4.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—atherosclerosis	3.62e-06	4.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—atherosclerosis	3.55e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—atherosclerosis	3.49e-06	4.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.47e-06	4.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—atherosclerosis	3.46e-06	4.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD36—atherosclerosis	3.45e-06	4.45e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—atherosclerosis	3.39e-06	4.36e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.27e-06	4.22e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARA—atherosclerosis	3.21e-06	4.14e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.19e-06	4.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.16e-06	4.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AGT—atherosclerosis	3.11e-06	4.01e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—atherosclerosis	3.05e-06	3.92e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAV1—atherosclerosis	3.02e-06	3.89e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA1—atherosclerosis	3.01e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.75e-06	3.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—atherosclerosis	2.65e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—INS—atherosclerosis	2.6e-06	3.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—atherosclerosis	2.39e-06	3.07e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—atherosclerosis	2.31e-06	2.97e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—atherosclerosis	2.28e-06	2.94e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—atherosclerosis	2.26e-06	2.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.09e-06	2.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—atherosclerosis	1.95e-06	2.52e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—atherosclerosis	1.94e-06	2.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—atherosclerosis	1.74e-06	2.25e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—atherosclerosis	1.7e-06	2.19e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—atherosclerosis	1.6e-06	2.07e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—atherosclerosis	1.59e-06	2.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.05e-06	1.35e-05	CbGpPWpGaD
